Market Overview

Morning Market Losers

Share:
Related PPHM
Earnings Scheduled For July 14, 2015
Peregrine Pharmaceuticals Granted Key European Patent for Its Lead Clinical Drug Candidate Bavituximab
Despite Good News, Peregrine Pharmaceuticals is Hangin' By a Thread (PPHM) (Small Cap Network)
Related QCOR
There's A Reason Mallinckrodt Continues To Disclose A Protracted, Multi-Agency Probe Of Recently-Acquired Questcor Pharmaceuticals
Kase Fund's Top 10 Stocks In 2015

Peregrine Pharmaceuticals (NASDAQ: PPHM) fell 74.58% to $1.37 at 10:55 am. Peregrine Pharmaceuticals reported that it discovered major discrepancies in its Phase II trial data of bavituximab.

Questcor Pharmaceuticals (NASDAQ: QCOR) shares dipped 31.50% to $20.64. Analysts at ThinkEquity downgraded Questcor from “buy” to “hold.”

Daegis (NASDAQ: DAEG) dropped 19.08% to $1.40. Daegis' trailing-twelve-month ROE is -110.48%.

Dialogic (NASDAQ: DLGC) shares lost 19% to $2.60. Dialogic shares have dipped 72.56% over the past 52 weeks, while the S&P 500 index has gained 25.57% in the same period.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets

 

Related Articles (DAEG + DLGC)

Get Benzinga's Newsletters